Nancy L. Kuntz

13.1k total citations · 1 hit paper
102 papers, 3.5k citations indexed

About

Nancy L. Kuntz is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Nancy L. Kuntz has authored 102 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 36 papers in Genetics and 22 papers in Neurology. Recurrent topics in Nancy L. Kuntz's work include Neurogenetic and Muscular Disorders Research (36 papers), Muscle Physiology and Disorders (22 papers) and Multiple Sclerosis Research Studies (14 papers). Nancy L. Kuntz is often cited by papers focused on Neurogenetic and Muscular Disorders Research (36 papers), Muscle Physiology and Disorders (22 papers) and Multiple Sclerosis Research Studies (14 papers). Nancy L. Kuntz collaborates with scholars based in United States, Germany and Italy. Nancy L. Kuntz's co-authors include Jacqueline Palace, Arthur Melms, Michael Benatar, Pushpa Narayanaswami, Janice M. Massey, Hiroyuki Murai, Donald B. Sanders, Gil I. Wolfe, Michael Nicolle and David P. Richman and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nancy L. Kuntz

93 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus guidance for management of myasthenia gravis

2016 710 citations Donald B. Sanders, Gil I. Wolfe et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy L. Kuntz United States	28	1.9k	794	740	541	521	102	3.5k
Michael Nicolle Canada	24	2.2k 1.2×	452 0.6×	371 0.5×	245 0.5×	105 0.2×	58	3.1k
F. Cornelio Italy	39	1.4k 0.7×	182 0.2×	2.0k 2.7×	551 1.0×	414 0.8×	134	4.3k
Wilson W. Bryan United States	32	2.4k 1.3×	150 0.2×	763 1.0×	445 0.8×	788 1.5×	46	4.1k
C. Michel Harper United States	37	1.8k 0.9×	334 0.4×	692 0.9×	1.1k 2.0×	166 0.3×	89	3.5k
David S. Younger United States	25	1.4k 0.7×	241 0.3×	365 0.5×	363 0.7×	212 0.4×	114	2.5k
David Hunt United Kingdom	28	524 0.3×	349 0.4×	712 1.0×	218 0.4×	364 0.7×	65	2.7k
Laurent Magy France	31	2.0k 1.1×	611 0.8×	587 0.8×	135 0.2×	358 0.7×	165	3.8k
Simmons Lessell United States	38	1.9k 1.0×	911 1.1×	697 0.9×	660 1.2×	269 0.5×	183	4.6k
Bruno Giometto Italy	39	3.5k 1.9×	400 0.5×	827 1.1×	146 0.3×	239 0.5×	122	5.3k
Raffaele Iorio Italy	32	1.7k 0.9×	1.0k 1.3×	438 0.6×	97 0.2×	102 0.2×	126	2.9k

Countries citing papers authored by Nancy L. Kuntz

Since Specialization

Citations

This map shows the geographic impact of Nancy L. Kuntz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy L. Kuntz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy L. Kuntz more than expected).

Fields of papers citing papers by Nancy L. Kuntz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy L. Kuntz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy L. Kuntz. The network helps show where Nancy L. Kuntz may publish in the future.

Co-authorship network of co-authors of Nancy L. Kuntz

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy L. Kuntz. A scholar is included among the top collaborators of Nancy L. Kuntz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy L. Kuntz. Nancy L. Kuntz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Proud, Crystal M., Richard S. Finkel, Julie Parsons, et al.. (2025). Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy. Journal of Clinical Investigation. 135(22). 1 indexed citations

Schroth, Mary, J. Deans, Kapil Arya, et al.. (2024). Spinal Muscular Atrophy Update in Best Practices. Neurology Clinical Practice. 14(4). e200310–e200310. 9 indexed citations

Kuntz, Nancy L., et al.. (2024). Prevalence of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Individuals With Dystrophinopathy at a Tertiary Care Center in Chicago. Pediatric Neurology. 158. 94–99. 1 indexed citations

Rao, Vamshi K., et al.. (2024). Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy. Journal of Clinical Medicine. 13(4). 921–921.

Finkel, Richard S., Basil T. Darras, Jerry R. Mendell, et al.. (2023). Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG). Journal of Neuromuscular Diseases. 10(3). 389–404. 30 indexed citations

Kuntz, Nancy L., et al.. (2023). Expansion of the phenotypic spectrum associated with pathogenic missense variation in DHX16. American Journal of Medical Genetics Part A. 194(1). 53–58. 2 indexed citations

Krosschell, Kristin J., et al.. (2023). Longitudinal Assessment of Timed Function Tests in Ambulatory Individuals with SMA Treated with Nusinersen. Journal of Neuromuscular Diseases. 10(3). 337–348. 1 indexed citations

Narayanaswami, Pushpa, Donald B. Sanders, Gil I. Wolfe, et al.. (2020). International Consensus Guidance for Management of Myasthenia Gravis. Neurology. 96(3). 114–122. 389 indexed citations

Hurley, Michael C., Pouya Nazari, Sameer A. Ansari, et al.. (2019). Transforaminal Intrathecal Access for Injection of Nusinersen in Adult and Pediatric Patients with Spinal Muscular Atrophy. Journal of Pediatric Neurology. 18(2). 88–94. 4 indexed citations

10.

Finkel, Richard S., John Day, Basil T. Darras, et al.. (2019). Phase 1 Study of Intrathecal Administration of AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 2 (SMA2) (STRONG) (P1.6-059). Neurology. 92(15_supplement). 2 indexed citations

11.

Graham, Robert J., Francesco Muntoni, Imelda Hughes, et al.. (2019). Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis. Archives of Disease in Childhood. 105(4). 332–338. 25 indexed citations

12.

Glascock, Jacqueline, Jacinda B. Sampson, Amanda Haidet-Phillips, et al.. (2018). Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening. Journal of Neuromuscular Diseases. 5(2). 145–158. 143 indexed citations

13.

Kirschner, Janbernd, Eugenio Mercuri, Richard S. Finkel, et al.. (2017). Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study. Neuropediatrics. 48.

14.

Sanders, Donald B., Gil I. Wolfe, Michael Benatar, et al.. (2016). INTERNATIONAL CONSENSUS GUIDANCE FOR THE MANAGEMENT OF MYASTHENIA GRAVIS. Muscle & Nerve. 54. 647–647.

15.

Sanders, Donald B., Gil I. Wolfe, Michael Benatar, et al.. (2016). International consensus guidance for management of myasthenia gravis. Neurology. 87(4). 419–425. 710 indexed citations breakdown →

16.

Chitnis, Tanuja, Charles R.G. Guttmann, Alexander Musallam, et al.. (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurology. 13(1). 173–173. 5 indexed citations

17.

Chitnis, Tanuja, Lauren Krupp, E. Ann Yeh, et al.. (2011). Pediatric Multiple Sclerosis. Neurologic Clinics. 29(2). 481–505. 64 indexed citations

18.

Chabas, Dorothée, Dorothée Chabas, Dorothée Chabas, et al.. (2011). Demyelinating Disorders of the Central Nervous System in Childhood. Cambridge University Press eBooks. 7 indexed citations

19.

Wong‐Kisiel, Lily C. & Nancy L. Kuntz. (2010). Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort. Neuromuscular Disorders. 20(2). 122–124. 21 indexed citations

20.

Escolar, Diana M., Carolina Tesi Rocha, Paula R. Clemens, et al.. (2007). G.P.9.09 Immediate release oral pentoxifylline is poorly tolerated in Duchenne muscular dystrophy boys. Neuromuscular Disorders. 17(9-10). 817–817. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact